Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Interest Coverage Ratio (2016 - 2025)

United Therapeutics' Interest Coverage Ratio history spans 17 years, with the latest figure at 115.06 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 154.13% year-over-year to 115.06; the TTM value through Dec 2025 reached 76.54, up 138.45%, while the annual FY2025 figure was 76.54, 138.45% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 115.06 at United Therapeutics, down from 129.5 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 129.5 in Q3 2025 and bottomed at 14.09 in Q1 2021.
  • The 5-year median for Interest Coverage Ratio is 34.07 (2022), against an average of 41.61.
  • The largest annual shift saw Interest Coverage Ratio tumbled 169.29% in 2021 before it skyrocketed 534.99% in 2022.
  • A 5-year view of Interest Coverage Ratio shows it stood at 36.13 in 2021, then tumbled by 60.48% to 14.28 in 2022, then increased by 20.65% to 17.23 in 2023, then skyrocketed by 162.86% to 45.28 in 2024, then soared by 154.13% to 115.06 in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Interest Coverage Ratio are 115.06 (Q4 2025), 129.5 (Q3 2025), and 49.93 (Q2 2025).